The elucidation of the primary structure of insulin by Sanger's group in 1955 and its three-dimensional structure by Hodgkin's group in 1969 and a group in Beijing in 1973 has paved the way to investigating the function of insulin in relation to its structure. From the information provided by the structural analysis and functional studies, we are interested in the C-terminal part of the insulin B-chain. This part has been proposed to be involved in receptor binding and in exhibiting the negative-co-operative effect in the binding reaction (De Meyts et al., 1978) . In order to prepare analogues with modified sequences in this part of the molecule a semisynthetic method was worked out (Shanghai Insulin Research Group, 1973) . It consists of the following steps: tryptic digestion of insulin ester to desoctapeptide (B-23-B-30) insulin (DOI) ester, protection of amino groups, coupling with synthetic peptide ester and deprotection of the semisynthetic product. Using this method, an active fragment of insulin, deshexapeptide (B-25-B-30) insulin (DHI), was obtained. The addition of glycylphenylalanine to the C-terminal arginine residue of DO1 has the remarkable effect of converting the inactive DO1 into active DHI with 40% of insulin activity in a mouse-convulsion assay. This result is consistent with studies along other lines. In comparative studies of insulin from different species, B-23 Gly and B-24 Phe are invariably conserved. In human beings an abnormal insulin with B-24 or B-25 phenylalanine replaced by leucine was found in a diabetic patient (Tager et al., 1979) .
The advantage of semisynthesis is obvious because we can use the ready-made natural peptide, for example DO1 from insulin. However, the functional groups of the natural peptide that are not to be allowed to react must be protected as usual. Unfortunately, the C-terminius of insulin A-chain happens to be asparagine, which forms a cyclic imide during esterification and saponification (Gattner & Schmitt, 1977) . This side-reaction prevented us from obtaining a homogeneous product. The problem was eventually solved by using enzymic semisynthesis. When the condensation of DO1 and glycylphenylalanine was performed in a suitable co-solvent and catalysed by trypsin, but not in an organic solvent and coupled by dicyclohexylcarbodi-imide, no esterification of carboxy groups was necessary. Through tryptic semisynthesis, homogeneous DHI has been obtained in crystalline form (Cao ef al., 1981) . The biological activity of DHI in viuo is 40% compared with insulin; its binding capacity with the insulin receptor on the human placental membrane is only 2%, much lower than that of insulin (Cui el al., 1983) . Hence the biological activity and binding capacity of DHI are far from parallel; the difference between them is more than one order of magnitude. This difference may not be meaningful if DHI has a much longer half-life in the circulation and its activity in vivo is much higher than its Vol. 1 1 intrinsic biological activity. This situation was observed in A-1-B-29 cross-linked insulin (Jones et af., 1976) , which is also less susceptible to peptic and tryptic digestion (Wang et al., 1981) . But similar behaviour seems unlikely to occur in DHI, which shows no resistance to proteolytic enzymes. We will look into this possibility later. At present, we tend to think that the molecule of insulin may have some 'division of labour' in receptor binding and in triggering the biological response. One can visualize that one part of the molecule is involved in hormone-receptor recognition and thus important for target-cell specificity, whilst another part carries the hormone message. We can call them, respectively, binding site and message site (or address part and message part, which are analogous to what we have in a letter, as proposed by Robert Schwyzer in his study on corticotropin). The binding capacity depends on the integrity of the binding site, but the final biological effect depends also on the integrity of the message site. In the insulin molecule, the situation is more complicated than in corticotropin, because insulin as a typical globular protein has its unique conformation. Modification of a certain part of the molecule usually leads to an overall change of the native conformation, so it is hard to say that the part modified is directly involved in the function which has been changed. However, the very low binding capacity of DHI in contrast with its high biological activity implies that the binding site of DHI has been changed appreciably while its message site remains almost intact. Therefore, these two sites must be relatively independent. In addition, most probably the overall conformation of insulin is not changed appreciably by removing the last six residues of the B-chain, because otherwise both the binding site and the message site would be changed appreciably. In the case of insulin, its binding capacity is much higher than that of DHI, but its biological activity compared with DHI is not much higher. This probably indicates that the limiting factor or bottleneck for the expression of insulin activity is not the receptor-binding step but one of the post-binding steps. When receptor binding has reached a certain level, increasing binding will not bring about a corresponding increase in biological response. A similar situation was reported by Kono and Barham (197 l) , who found that the maximum insulin activity required to stimulate the oxidation of glucose in adipocytes was observed when only 2.4% of the receptors were occupied. This phenomenon was explained by the spare-receptor hypothesis.
There is another way to get DHI, by limited peptic hydrolysis of insulin, despentapeptide (B-26-B-30) insulin (DPI) was obtained. But with some preparations of DPI, for some unknown reason, a variable amount of DHI was present (Lu & Yu, 1980) . We can separate DHI from DPI by high-pressure liquid chromatography (Gan et al., 1983) (Fig. 1) . This may be a simpler method for obtaining DHI itself. But for the preparation of DHI analogues with B-23 Gly and B-24 Phe substituted, we still have to use enzymic synthesis. Recently, we have prepared ITrpe-z41DHI by enzymic synthesis in which the BIOCHEMICAL SOCIETY TRANSACTIONS methyl ester of tryptophan was used and the synthetic product saponified because tryptophan is alkali-stable but acid-labile (Fig. 2) . [TrpB-Z41DHI has lower insulin activity (about 7%) than DHI and it may be useful in studying the environment of the B-24 residue by spectrofluorimetry. (Fig. 3) . The first step is enzymic and specific to the carboxy group of B-22 Arg. The second step is non-enzymic and non-specific, which is essential in dealing with D-amino acid residues. The specific conversion of the B-22-Arg carboxy group in DO1 into acyl hydrazide by the action of trypsin was first reported by Canova-Davis & Carpenter (1980) . We have modified the method by using a higher concentration of DOI, higher temperature and pH (37OC and pH 7); a yield of over 60% was obtained, as shown by polyacrylamide-gel electrophoresis and DEAE-Sephadex chromatography. The next step, including azide formation and coupling with D-Ala-Phe-OBu' (OBu' = t- Insulins from different species are analogues formed in the course of evolution and are very useful in structure-and-function studies. We have worked out a simple method for isolating these analogues. Insulins of chicken, snake and goose (Xu et al., 1982) have been isolated in crystalline form. The crystalline shape of snake insulin is very unusual, it is dodecahedral instead of rhombohedral. Snake 8-granules were studied by Watari & Hotta (1976) , by high-voltage electron microscopy, and by Lange (1980) , by electron microscopy and electron diffraction. They also found dodecahedral microcrystals and two possible space groups; P4,32 and P2,3 were proposed by Lange (1980) . The space group of snake insulin we studied is P4,32 with 24 general positions, the unit cell is cubic with a equal to 0.673 1 nm (67.3 1 A) and contains 24 molecules in the form of four hexamers (Liang et al., 1983) . In each hexamer, three 2-fold axes are perpendicular to a 3-fold axis, and each asymmetric unit contains only one molecule of insulin. Goose insulin was also crystallized and has been sequenced (Xu et al., 1982) . It is similar to snake insulin in crystalline shape (Fig. 4) and identical with duck insulin in sequence. In the course of isolating insulin, goose C-peptide and pancreatic polypeptide were obtained as by-products and these have also been partially sequenced.
(R = Z IIFJ -lFcI~/Z~F,J) of 0.21 was obtained (Wang et al., 1982aJ ). The refinement of the insulin structure at 0.12nm (1.2 A) resolution is now in progress.
Although the determination and refinement of the crystal structure of insulin has given us very important structural information on the relationship between the structure and and LOU MEI-ZHEN VOl. 11 function of insulin, it is still unable to elucidate the mechanism of insulin action. Therefore the determination of the threedimensional structures of a series of insulin analogues and the analysis of the fine differences in their conformations will undoubtedly be significant for studying the structure-function relationship of insulin.
X-ray-crystallographic studies on some insulin analogues mod$ed at the N-terminus of the B-chain
The N-terminus of the B-chain is one of the important regions for studying the structure-function relationship of insulin. For a long time, it was considered that the B-chain N-terminus was mainly important for immunological reactivity and not so important for biological activity The studies on des-(BlPhe)-insulin, which retains almost complete biological activity as compared with insulin, supported this point of view (Brandenburg, 1969) . However, extensive investigations on this region (Saunders et al., 1977) have shown that the B-chain N-terminal residues may in some way be involved in the interaction of insulin with its receptor. Therefore studies on the three-
